Search Results
Search for other papers by Joke Marlier in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Jean Kaufman in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
/kg body weight, aiming for free thyroxine serum levels (fT4) prior to intake in the upper part of normal reference ranges ( 1 ). However, variability in TH absorption and metabolism, concomitant treatments and inaccurate interpretation of TSH levels still
Search for other papers by Roberto Fiore in
Google Scholar
PubMed
Search for other papers by Stefano La Rosa in
Google Scholar
PubMed
Search for other papers by Silvia Uccella in
Google Scholar
PubMed
Search for other papers by Deborah Marchiori in
Google Scholar
PubMed
Search for other papers by Peter A Kopp in
Google Scholar
PubMed
4.5 mU/L (reference range 0.27-4.2 mU/L), with normal levels of fT4 (16 pmol/L, reference range 12.0–22.0 pmol/L) and fT3 (4 pmol/L, reference range 3.1–6.8 pmol/L) ( Table 1 ). He was subsequently started on systemic therapy with the tyrosine kinase
Search for other papers by Paolo Cavarzere in
Google Scholar
PubMed
Search for other papers by Laura Palma in
Google Scholar
PubMed
Search for other papers by Lara Nicolussi Principe in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Monica Vincenzi in
Google Scholar
PubMed
Search for other papers by Silvana Lauriola in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Rossella Gaudino in
Google Scholar
PubMed
Search for other papers by Virginia Murri in
Google Scholar
PubMed
Search for other papers by Luigi Lubrano in
Google Scholar
PubMed
Search for other papers by Giuliana Rossi in
Google Scholar
PubMed
Search for other papers by Alessia Sallemi in
Google Scholar
PubMed
Search for other papers by Ermanna Fattori in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Marta Camilot in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Regional Center for the Diagnosis and Treatment of Children and Adolescents Rare Skeletal Disorders, Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Franco Antoniazzi in
Google Scholar
PubMed
( 17 , 18 ), we considered thyroid function as normal in the newborn when FT4 was in the reference range in the presence of a TSH level below 6 mU/L; in these cases, no further tests were required. When FT4 was in the reference range and TSH level was
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Kamilla R Riis in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla B Larsen in
Google Scholar
PubMed
Search for other papers by Bjarke R Medici in
Google Scholar
PubMed
Search for other papers by Christian Z Jensen in
Google Scholar
PubMed
Search for other papers by Kristian H Winther in
Google Scholar
PubMed
Search for other papers by Emil L Larsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Data and Data Support, Region Zealand, Sorø, Denmark
Search for other papers by Christina Ellervik in
Google Scholar
PubMed
Search for other papers by Jeppe L la Cour in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Thomas H Brix in
Google Scholar
PubMed
Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
Department of Cardiology, University Hospital Nordsjælland, Hillerød, Denmark
Search for other papers by Henrik E Poulsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
the reference range of 0.3–4.0 mIU/L and total plasma thyroxine (TT4) below the reference range of 60–130 nmol/L) or mild (plasma TSH above the reference range, and plasma TT4 within the reference range). Exclusion criteria were pregnancy or planned
Search for other papers by Maja Hjelm Lundgaard in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Ulla Birgitte Christiansen in
Google Scholar
PubMed
Department of Gynaecology and Obstetrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Anne Sørensen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Søren Risom Kristensen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
diagnosis of hypothyroidism was made, treatment with levothyroxine (50 µg per day) was unaltered. Biochemical assessment revealed improvement in patient thyroid function and TSH as well as T4 and T3 were within the reference ranges at 6 months follow
Department of Pediatric Endocrinology, Faculty of Medicine, Istinye University, Istanbul, Turkey
Search for other papers by Cengiz Kara in
Google Scholar
PubMed
Search for other papers by Jamala Mammadova in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Ümmet Abur in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Cagri Gumuskaptan in
Google Scholar
PubMed
Search for other papers by Elif İzci Güllü in
Google Scholar
PubMed
Search for other papers by Ayhan Dağdemir in
Google Scholar
PubMed
Search for other papers by Murat Aydın in
Google Scholar
PubMed
and free thyroxine (FT4) measurements, according to laboratory reference values (see supplementary material for reference ranges). All CH patients with low serum FT4 and/or persistently high (>10 µU/mL) TSH were treated with l -thyroxine (LT4). Two
Search for other papers by Frederick Keen in
Google Scholar
PubMed
Search for other papers by Anuja Chalishazar in
Google Scholar
PubMed
Search for other papers by Kelly Mitchem in
Google Scholar
PubMed
Search for other papers by Alan Dodd in
Google Scholar
PubMed
Search for other papers by Atul Kalhan in
Google Scholar
PubMed
criteria. Age >16 years A low free T4 <11.0 pmol/L (reference range: 11–25) A low-normal or low TSH Referred to endocrinology for investigation Results A total of 151 TFTs results were identified using the pre
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla Bøgelund Larsen in
Google Scholar
PubMed
Search for other papers by Kristian Hillert Winther in
Google Scholar
PubMed
Search for other papers by Per Karkov Cramon in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Nils Jakob Knudsen in
Google Scholar
PubMed
QualityMetric Inc, Johnston, Lincoln, Rhode Island, USA
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Search for other papers by Lutz Schomburg in
Google Scholar
PubMed
Search for other papers by Kamil Demircan in
Google Scholar
PubMed
Search for other papers by Thilo Samson Chillon in
Google Scholar
PubMed
Search for other papers by Jeppe Gram in
Google Scholar
PubMed
Search for other papers by Stinus Gadegaard Hansen in
Google Scholar
PubMed
Internal Medicine Research Unit, University Hospital of Southern Jutland, Aabenraa, Denmark
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
the LT4 dose, aiming for a serum TSH level within the reference range. Inclusion criteria Inclusion criteria were age ≥18 years; diagnosis of AIT with serum TPOAb ≥100 kIU/L measured within the last 12 months; LT4 treatment based on an initial
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
concentrations within the reference range. Furthermore, patients detected at a later age had normal neurological development which implies that during childhood, TH was sufficiently produced. Clinical manifestations predominantly concern growth abnormalities ( 20
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Bronia Arnott in
Google Scholar
PubMed
Search for other papers by Dawn Teare in
Google Scholar
PubMed
Search for other papers by Shaun Hiu in
Google Scholar
PubMed
Search for other papers by Nicki O’Brien in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is a mild form of thyroid failure diagnosed when serum TSH levels are high and circulating thyroid hormones are within the reference range [ 1 , 2 ]. The prevalence of SCH increases with age and